Biotinylated Human BTLA (31-134) Protein, Fc, Avitag™ | BTA-H82F8-25ug

Biotinylated Human BTLA (31-134) Protein, Fc, Avitag™ | BTA-H82F8-25ug| Gentaur Distribution US, UK & Europe

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

Source: Biotinylated Human BTLA (31-134), Fc, Avitag (BTA-H82F8) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Thr 134 (Accession # Q7Z6A9).

Format: Powder.

Tag: C-Fc & C-Avi.

Expression System: HEK293.

Expression Region: Lys 31 - Thr 134.

Conjugate: Biotin-labeled.

Molecular Weight: 40.5 kDa.

Characteristics: This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 40.5 kDa. The protein migrates as 55-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 95%.

Buffer: Tris with Glycine,  Arginine and NaCl,  pH7.5.

Storage Conditions: -20℃.

Shipping Conditions: RT